Abstract:Environmental pollution remains a pressing global concern, with a substantial number of annual fatalities attributed to pollution-induced diseases. One emerging facet of environmental pollution is drug contamination, whereby pharmaceutical compounds can readily infiltrate water sources during manufacturing or utilization, subsequently being detected in various aquatic ecosystems. Some drugs have been detected in many watersheds at concentrations that can cause toxicity to aquatic organisms. Isavuconazonium sulfate (ISAV-SF), a prevalent antifungal medication, is no exception, warranting an exploration of its potential toxicity. However, limited research has been conducted in this domain. In this investigation, zebrafish were employed as a model organism to scrutinize the cardiotoxicity of ISAV-SF. Exposure of zebrafish embryos to concentrations of 0.5, 0.75, and 1 mg/L of ISAV-SF resulted in noteworthy cardiac developmental aberrations. These anomalies encompassed enlarged pericardial area, diminished heart rate, alterations in SV-BA distance, and the detachment of cardiomyocytes from the endocardium. Exposure to ISAV-SF caused disruption of the expression of genes related to cardiac development (gata4, klf2a, nkx2.5, vmhc, tbx2b), especially in the high concentration group. Moreover, the Notch signaling pathway was inhibited and oxidative stress levels were upregulated in all exposed groups. Remarkably, the administration of the antioxidant astaxanthin effectively mitigated oxidative stress levels, thus ameliorating heart developmental impairments. These results suggest that ISAV-SF may contribute to cardiac developmental defects by upregulating oxidative stress. This study serves as a pivotal reference for the utilization of ISAV-SF within the market, emphasizing the necessity to curtail its introduction into aquatic environments during production and consumption and to evaluate its repercussions on aquatic organisms.

Developmental toxicity caused by sanguinarine in zebrafish embryos via regulating oxidative stress, apoptosis and wnt pathways

Cardiotoxicity of Sanguinarine Via Regulating Apoptosis and MAPK Pathways in Zebrafish and HL1 Cardiomyocytes

Sanguinarine exposure induces immunotoxicity and abnormal locomotor behavior in zebrafish

Neurotoxicity of sanguinarine via inhibiting mitophagy and activating apoptosis in zebrafish and PC12 cells

The effects of CdSe/ZnS quantum dots on embryonic development of zebrafish

SYP-3343 Drives Abnormal Vascularization in Zebrafish Through Regulating Endothelial Cell Behavior

Developmental toxicity assay of xanthatin in zebrafish embryos

Developmental toxicity induced by chelerythrine in zebrafish embryos via activating oxidative stress and apoptosis pathways

Adverse Effect of Cylindrospermopsin on Embryonic Development in Zebrafish (danio Rerio).

The Embryonic Developmental Effect of Sedaxane on Zebrafish (danio Rerio).

Developmental Toxicity of Diclofenac and Elucidation of Gene Regulation in zebrafish (Danio rerio)

Effect of Acute Exposure of Saxitoxin on Development of Zebrafish Embryos (danio Rerio)

Toxic Effects of Strychnine and Strychnine N-oxide on Zebrafish Embryos

Toxic effect of microcystin-LR on blood vessel development

Evaluation of the Developmental Toxicity Induced by E804 in Zebrafish Embryos.

Isavuconazonium sulfate induces heart development defects in zebrafish larvae by upregulation of oxidative stress

Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years

Induction of Hepatotoxicity by Sanguinarine is Associated with Oxidation of Protein Thiols and Disturbance of Mitochondrial Respiration

Toxicity and Related Molecular Mechanisms of Sb(III) in the Embryos and Larvae of Zebrafish (danio Rerio)

Transcriptome analysis of developing zebrafish (Danio rerio) embryo following exposure to Gaudichaudione H reveals teratogenicity and cardiovascular defects caused by abnormal iron metabolism

Sanguinarine Protects Against Pressure Overload-Induced Cardiac Remodeling Via Inhibition Of Nuclear Factor-Kappa B Activation